Enamel matrix derivative induces production of vascular endothelial cell growth factor in human gingival fibroblasts

European Journal of Oral Sciences

Volumn 120, Issue 6, 2012, Pages 513-519

  Sakoda, Kenji ^a   Nakajima, Yumiko ^a   Noguchi, Kazuyuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Enamel matrix derivative; Fibroblast growth factor 2 (FGF 2); Gingival fibroblast; Transforming growth factor 1 (TGF 1); Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENIC FACTOR; ENAMEL PROTEIN; ENZYME INHIBITOR; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ANALYSIS OF VARIANCE; ARTICLE; CELL CULTURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION PROFILING; GENETICS; GINGIVA; HUMAN; METABOLISM; PHOSPHORYLATION; WOUND HEALING;

ANALYSIS OF VARIANCE; ANGIOGENESIS INDUCING AGENTS; CELLS, CULTURED; DENTAL ENAMEL PROTEINS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GENE EXPRESSION PROFILING; GINGIVA; HUMANS; PHOSPHORYLATION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84869884772     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2012.00999.x     Document Type: Article

References (43)

1. Grote K, Schutt H, Schieffer B. Toll-like receptors in angiogenesis. ScientificWorldJournal 2011; 11: 981-991.
2. Mizia-Malarz A, Sobol G, Wos H. [Proangiogenic factors: vascular-endothelial growth factor (VEGF) and basic fibroblast growth factor-the characteristics and function]. Przegl Lek 2008; 65: 353-357.
3. Brown LF, Van de Water L, Harvey VS, Dvorak HF. Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. Am J Pathol 1988; 130: 455-465.
4. Breuing K, Eriksson E, Liu P, Miller DR. Healing of partial thickness porcine skin wounds in a liquid environment. J Surg Res 1992; 52: 50-58.
5. Moukadiri H, Favard C, Praloran V, Plouet J. [Vasculotropin: a new angiogenic growth factor]. Pathol Biol (Paris) 1991; 39: 153-156.
6. Kiselyov A, Balakin KV, Tkachenko SE. VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert Opin Investig Drugs 2007; 16: 83-107.
7. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674.
8. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25.
9. Kitamura M, Akamatsu M, Machigashira M, Hara Y, Sakagami R, Hirofuji T, Hamachi T, Maeda K, Yokota M, Kido J, Nagata T, Kurihara H, Takashiba S, Sibutani T, Fukuda M, Noguchi T, Yamazaki K, Yoshie H, Ioroi K, Arai T, Nakagawa T, Ito K, Oda S, Izumi Y, Ogata Y, Yamada S, Shimauchi H, Kunimatsu K, Kawanami M, Fujii T, Furuichi Y, Furuuchi T, Sasano T, Imai E, Omae M, Watanuki M, Murakami S. FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res 2011; 90: 35-40.
10. Esposito M, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev 2003; 2: CD003875.
11. Pagliaro U, Nieri M, Rotundo R, Cairo F, Carnevale G, Esposito M, Cortellini P, Pini-Prato G. Clinical guidelines of the Italian Society of Periodontology for the reconstructive surgical treatment of angular bony defects in periodontal patients. J Periodontol 2008; 79: 2219-2232.
12. Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2008; 35: 817-824.
13. Wennstrom JL, Lindhe J. Some effects of enamel matrix proteins on wound healing in the dento-gingival region. J Clin Periodontol 2002; 29: 9-14.
14. Thoma DS, Villar CC, Carnes DL, Dard M, Chun YH, Cochran DL. Angiogenic activity of an enamel matrix derivative (EMD) and EMD-derived proteins: an experimental study in mice. J Clin Periodontol 2011; 38: 253-260.
15. Aspriello SD, Zizzi A, Spazzafumo L, Rubini C, Lorenzi T, Marzioni D, Bullon P, Piemontese M. Effects of enamel matrix derivative on vascular endothelial growth factor expression and microvessel density in gingival tissues of periodontal pocket: a comparative study. J Periodontol 2011; 82: 606-612.
16. Nakajima Y, Furuichi Y, Biswas KK, Hashiguchi T, Kawahara K, Yamaji K, Uchimura T, Izumi Y, Maruyama I. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Lett 2006; 580: 613-619.
17. Kawase T, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodontal Res 2001; 36: 367-376.
18. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 1998; 141: 1659-1673.
19. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
20. Khalil N, Xu YD, O'Connor R, Duronio V. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem 2005; 280: 43000-43009.
21. Murakami-Mori K, Mori S, Nakamura S. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals. J Immunol 1998; 161: 1694-1704.
22. Goda S, Kaneshita Y, Inoue H, Domae E, Ikeo T, Iida J, Domae N. Enamel matrix derivative protein stimulated wound healing via phosphoinositide 3-kinase. J Periodontol 2009; 80: 1631-1637.
23. Schlueter SR, Carnes DL, Cochran DL. In vitro effects of enamel matrix derivative on microvascular cells. J Periodontol 2007; 78: 141-151.
24. Mirastschijski U, Konrad D, Lundberg E, Lyngstadaas SP, Jorgensen LN, Agren MS. Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen 2004; 12: 100-108.
25. Gestrelius S, Andersson C, Lidstrom D, Hammarstrom L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997; 24: 685-692.
26. Jepsen S, Schiltz P, Strong DD, Scharla SH, Snead ML, Finkelman RD. Transforming growth factor-beta 1 mRNA in neonatal ovine molars visualized by in situ hybridization: potential role for the stratum intermedium. Arch Oral Biol 1992; 37: 645-653.
27. D'Souza RN, Happonen RP, Ritter NM, Butler WT. Temporal and spatial patterns of transforming growth factor-beta 1 expression in developing rat molars. Arch Oral Biol 1990; 35: 957-965.
28. Suzuki S, Nagano T, Yamakoshi Y, Gomi K, Arai T, Fukae M, Katagiri T, Oida S. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-{beta}. J Dent Res 2005; 84: 510-514.
29. Wada Y, Yamamoto H, Nanbu S, Mizuno M, Tamura M. The suppressive effect of enamel matrix derivative on osteocalcin gene expression of osteoblasts is neutralized by an antibody against TGF-beta. J Periodontol 2008; 79: 341-347.
30. Hama H, Azuma H, Seto H, Kido J, Nagata T. Inhibitory effect of enamel matrix derivative on osteoblastic differentiation of rat calvaria cells in culture. J Periodontal Res 2008; 43: 179-185.
31. Van der Pauw MT, Van den Bos T, Everts V, Beertsen W. Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta1 release of periodontal ligament and gingival fibroblasts. J Periodontol 2000; 71: 31-43.
32. Maycock J, Wood SR, Brookes SJ, Shore RC, Robinson C, Kirkham J. Characterization of a porcine amelogenin preparation, EMDOGAIN, a biological treatment for periodontal disease. Connect Tissue Res 2002; 43: 472-476.
33. Grayson RE, Yamakoshi Y, Wood EJ, Agren MS. The effect of the amelogenin fraction of enamel matrix proteins on fibroblast-mediated collagen matrix reorganization. Biomaterials 2006; 27: 2926-2933.
34. Almqvist S, Kleinman HK, Werthén M, Thomsen P, Agren MS. Effects of amelogenins on angiogenesis-associated processes of endothelial cells. J Wound Care 2011; 20: 70-75.
35. Belgore F, Lip GY, Blann AD. Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells. Eur J Clin Invest 2003; 33: 833-839.
36. Kanno Y, Ishisaki A, Yoshida M, Tokuda H, Numata O, Kozawa O. SAPK/JNK plays a role in transforming growth factor-beta-induced VEGF synthesis in osteoblasts. Horm Metab Res 2005; 37: 140-145.
37. Takayama S, Yoshida J, Hirano H, Okada H, Murakami S. Effects of basic fibroblast growth factor on human gingival epithelial cells. J Periodontol 2002; 73: 1467-1473.
38. Kano MR, Morishita Y, Iwata C, Iwasaka S, Watabe T, Ouchi Y, Miyazono K, Miyazawa K. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 2005; 118: 3759-3768.
39. Menu E, Kooijman R, Van Valckenborgh E, Asosingh K, Bakkus M, Van Camp B, Vanderkerken K. Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Br J Cancer 2004; 90: 1076-1083.
40. Kim IS, Song YM, Hwang SJ. Osteogenic responses of human mesenchymal stromal cells to static stretch. J Dent Res 2010; 89: 1129-1134.
41. Hanai Y, Tokuda H, Yasuda E, Noda T, Ohta T, Takai S, Kozawa O. Up-regulation by zinc of FGF-2-induced VEGF release through enhancing p44/p42 MAP kinase activation in osteoblasts. Life Sci 2006; 80: 230-234.
42. Tokuda H, Hirade K, Wang X, Oiso Y, Kozawa O. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts. J Endocrinol 2003; 177: 101-107.
43. Takai S, Tokuda H, Hanai Y, Kozawa O. Activation of phosphatidylinositol 3-kinase/Akt limits FGF-2-induced VEGF release in osteoblasts. Mol Cell Endocrinol 2007; 267: 46-54.